Renaissance Technologies - ELOXX PHARMACEUTICALS INC ownership

ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 39 filers reported holding ELOXX PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ELOXX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$23,000
-52.1%
133,500
-25.6%
0.00%
Q2 2022$48,000
-85.3%
179,400
+9.5%
0.00%
Q2 2021$326,000
+106.3%
163,900
+312.5%
0.00%
Q4 2020$158,000
+0.6%
39,733
-33.3%
0.00%
Q3 2020$157,000
-42.7%
59,533
-34.1%
0.00%
Q2 2020$274,000
+7.0%
90,333
-30.9%
0.00%
Q1 2020$256,000
-74.5%
130,810
-4.2%
0.00%
-100.0%
Q4 2019$1,005,000
+992.4%
136,510
+572.1%
0.00%
Q3 2019$92,000
-46.2%
20,310
+103.1%
0.00%
Q2 2018$171,00010,0000.00%
Other shareholders
ELOXX PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 1,950,949$1,092,0000.45%
AMERICAN FINANCIAL GROUP INC 1,480,000$829,0000.25%
Vanguard Capital Wealth Advisors 158,900$86,0000.06%
Atom Investors LP 113,151$63,0000.03%
Nantahala Capital Management 774,767$434,0000.02%
MENORA MIVTACHIM HOLDINGS LTD. 2,094,208$1,173,0000.02%
Harel Insurance Investments & Financial Services Ltd. 1,176,401$659,0000.01%
Altshuler Shaham Ltd 1,088,848$609,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 309,400$173,0000.00%
Clal Insurance Enterprises Holdings Ltd 585,000$328,0000.00%
View complete list of ELOXX PHARMACEUTICALS INC shareholders